Diversified Trust Co Decreases Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Diversified Trust Co decreased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 11.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,837 shares of the company’s stock after selling 2,826 shares during the quarter. Diversified Trust Co’s holdings in Bath & Body Works were worth $1,042,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of BBWI. Atlas Capital Advisors LLC increased its holdings in shares of Bath & Body Works by 3.8% in the 1st quarter. Atlas Capital Advisors LLC now owns 14,063 shares of the company’s stock valued at $703,000 after purchasing an additional 521 shares in the last quarter. Kwmg LLC increased its holdings in Bath & Body Works by 1.0% in the first quarter. Kwmg LLC now owns 119,526 shares of the company’s stock valued at $5,979,000 after buying an additional 1,136 shares in the last quarter. First Financial Corp IN lifted its position in shares of Bath & Body Works by 30.0% during the 1st quarter. First Financial Corp IN now owns 2,571 shares of the company’s stock valued at $129,000 after acquiring an additional 594 shares during the period. FCF Advisors LLC boosted its stake in shares of Bath & Body Works by 9.7% during the 1st quarter. FCF Advisors LLC now owns 35,055 shares of the company’s stock worth $1,753,000 after acquiring an additional 3,112 shares in the last quarter. Finally, Contravisory Investment Management Inc. acquired a new stake in shares of Bath & Body Works in the 1st quarter worth approximately $487,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Trading Down 1.6 %

Shares of NYSE:BBWI opened at $38.44 on Tuesday. The firm has a market cap of $8.58 billion, a price-to-earnings ratio of 9.91, a PEG ratio of 1.29 and a beta of 1.85. The stock’s 50-day moving average price is $45.84 and its two-hundred day moving average price is $45.14. Bath & Body Works, Inc. has a 12-month low of $27.30 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Tuesday, June 4th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.05. The firm had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.37 billion. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. Bath & Body Works’s revenue was down .9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 earnings per share. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.29 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 21st. Investors of record on Friday, June 7th were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.08%. The ex-dividend date was Friday, June 7th. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.62%.

Analysts Set New Price Targets

BBWI has been the topic of a number of research analyst reports. Piper Sandler boosted their target price on Bath & Body Works from $44.00 to $45.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Bath & Body Works from $53.00 to $57.00 in a research report on Monday, June 3rd. JPMorgan Chase & Co. upgraded shares of Bath & Body Works from an “underweight” rating to a “neutral” rating and raised their target price for the company from $40.00 to $53.00 in a report on Friday, May 17th. The Goldman Sachs Group upped their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a report on Monday, March 4th. Finally, BMO Capital Markets raised their price objective on shares of Bath & Body Works from $50.00 to $55.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 5th. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Bath & Body Works currently has an average rating of “Hold” and an average target price of $48.53.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.